Rossari Biotech intimates SEBI-compliant earnings conference call for Q4 FY26 results on April 28, 2026.
Management will discuss financial results for quarter/year ended March 31, 2026, followed by Q&A session.
Senior management team will address the call, with pre-registration available for zero wait time access.
Company operates in specialty chemicals with manufacturing at Silvassa and Dahej across HPPC, textile, and AHN segments.